Pictet Asset Management (UK)’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-242,855
Closed -$34K 1027
2018
Q4
$34K Buy
242,855
+77,983
+47% +$11.8M 0.09% 284
2018
Q3
$28.2M Buy
164,872
+7,318
+5% +$1.23M 0.06% 338
2018
Q2
$27.3M Sell
157,554
-14,747
-9% -$2.22M 0.07% 330
2018
Q1
$19.9M Sell
172,301
-48,463
-22% -$5.15M 0.05% 380
2017
Q4
$18.6M Sell
220,764
-20,638
-9% -$1.72M 0.05% 393
2017
Q3
$22.2M Buy
241,402
+30,636
+15% +$2.38M 0.06% 344
2017
Q2
$9.62M Buy
+210,766
New +$11.7M 0.03% 485

Other funds holding LOXO

Pictet Asset Management (UK)'s LOXO Position: Q1 2019 in Review

Pictet Asset Management (UK) sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 242,855 shares — an estimated $34K sold.

Pictet Asset Management (UK) first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $28.2M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Pictet Asset Management (UK) reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 242,855 Loxo Oncology, Inc shares in Q1 2019, an estimated $34K.
  • Pictet Asset Management (UK) first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
  • Pictet Asset Management (UK)'s Loxo Oncology, Inc position peaked at $28.2M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2019, filed 10 May 2019.